ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report

ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report

English
4 Pages
Read
Download
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report PR Newswire ALBANY, New York, June 19, 2012 ALBANY, New York, June 19, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar GBI Research, the leading business intelligence provider, has released its latest research, Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar, which provides insights into bone metabolic disease therapeutics until 2018. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.com/bone-metabolism-therapeutics- market-to-2018-hyperparathyroidism-sector-to-decline-in-the- absence-of-new-product-launches-and-increased-generic-erosion-for- zemplar-hectorol-and-sensipar-report.html The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Subjects

Informations

Published by
Reads 7
Language English
Report a problem
ResearchMoz: Bone Metabolism Therapeutics
Market to 2018 - Hyperparathyroidism Sector to
Decline in the Absence of New Product
Launches and Increased Generic Erosion for
Zemplar, Hectorol and Sensipar- Market
Research Report
PR Newswire
ALBANY, New York, June 19, 2012
ALBANY, New York
,
June 19, 2012
/PRNewswire/ --
New Report Added in ResearchMoz Reports Database Bone
Metabolism Therapeutics Market to 2018 - Hyperparathyroidism
Sector to Decline in the Absence of New Product Launches and
Increased Generic Erosion for Zemplar, Hectorol and Sensipar
GBI Research, the leading business intelligence provider, has released its latest
research, Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism
Sector to Decline in the Absence of New Product Launches and Increased
Generic Erosion for Zemplar, Hectorol and Sensipar, which provides insights
into bone metabolic disease therapeutics until 2018.
To Browse Full TOC, Tables & Figures
visit:
http://www.researchmoz.com/bone-metabolism-therapeutics-
market-to-2018-hyperparathyroidism-sector-to-decline-in-the-
absence-of-new-product-launches-and-increased-generic-erosion-for-
zemplar-hectorol-and-sensipar-report.html
The report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI
Researchs team of industry experts. The report provides an in-depth analysis of
the major bone metabolic diseases, including osteoporosis, Pagets disease of
bone, hyperparathyroidism and bone metastases. The report also provides the
share of generics in global bone metabolic diseases as well as in each indication
market. It also provides the treatment algorithm flow for each of the four
indications. The report examines the global bone metabolic diseases treatment
usage patterns. In addition, the geographical distribution of bone metabolic
diseases and markets across the US, the top five countries of
Europe
, and in
Japan
, are provided in the report. The report also includes insights into the bone
metabolic diseases R&D product pipeline and explores the competitive
landscape, including major players in the bone metabolism therapeutics
market. Finally, the report also includes analysis of Mergers and Acquisitions
(M&As) and licensing agreements that took place in the bone metabolism
therapeutics market.
Related Market Research Reports on
Bone Market
Bone Cancer Pipeline Review
Optimizing Treatment for Bone Metastases in Patients with Advanced
Cancers
Bone Metastasis Global Clinical Trials Review
Bone Cancer Global Clinical Trials Review
Bone Graft Substitutes
ENT Devices Market
Bone Metastases Therapeutics - Pipeline Assessment
Bone and Joint Infection Market
Pagets disease of Bone
GBI Researchs analysis shows that the overall global bone metabolism
therapeutics market for the four indications (which includes osteoporosis,
Pagets disease of bone, hyperparathyroidism and bone metastases) was valued
at
$15 billion
in 2010, growing from
$10.1 billion
in 2002 and indicating a CAGR
of 5.2%. GBI Research forecasts the market to grow at a CAGR of 7.7%
between 2010 and 2018 to record a sales value of
$27.1 billion
by 2018. The
growth in the bone metabolism therapeutics market is mainly due to the
contribution of osteoporosis market. The revenue of osteoporosis market alone
has approximately 68% of the total bone metabolism revenue. So, the global
bone metabolism market is growing inspite of the declining market nature of
the rest of therapeutics areas discussed here.
Scope
- Data and analysis on the metabolic disorder therapeutics market in the
leading geographies of the world the US, the UK,
Germany
,
France
,
Italy
,
Spain
,
and
Japan
.
- Annualized market data for the metabolic disorder therapeutics market from
2002 to 2010, with forecasts to 2018 for the three indications osteoporosis,
Pagets disease of bone, hyperparathyroidism and bone metastases.
- Market data on the geographical landscape and therapeutic landscape,
including market size, market share, annual cost of therapy, sales volume and
treatment usage patterns such as disease population, treatment seeking
population, diagnosis population and prescription population.
- Share of the generics in the global bone metabolism therapeutics market and
for the market of each indication that is covered in the report.
- Key drivers and restraints that have had a significant impact on the market.
- The competitive landscape of the global bone metabolism therapeutics
market, including top companies benchmarking. The key companies studied in
this report are Amgen Inc., Abbott Laboratories, Genzyme Corporation, Merck
& Co. Inc. and Novartis AG.
- Key M&A activities and Licensing Agreements that took place in 2009 and
2011 in the metabolic disorders therapeutics market.
Reasons to buy
- Align your product portfolio to the markets with high growth potential.
- Build effective strategies to launch their pipeline products by identifying
potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products that
might fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top
competitors.
- Devise a more tailored country strategy through the understanding of key
drivers and barriers and market potential of each indication.
- Develop market-entry and market expansion strategies by identifying the
geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can
produce first-in-class molecules which are safer and more efficacious.
Report Category:
Pharmaceutical
Browse All
GBI Research Latest Reports & Industry Analysis
Latest Reports by GBI Research
Pharmaceutical Pricing and Reimbursement in China
Emerging Pharmaceutical Market in South Africa
Translational Regenerative Medicine Market
Workforce Reductions in Pharmaceuticals
Re-evaluating Pharmaceutical Pipelines
Biological Strategies in the Emerging Markets
Negative Pressure Wound Therapy Market
Ambient Energy Harvesters Market
Pico Projectors Market
Acrylonitrile Global Market
Advanced Batteries Market
Emerging Pharmaceutical Market in Indonesia and Philippines
Polyethylene Terephthalate (PET) Global Market
Prescribing Trends in Opioids
Drug Price Cuts in Top Five Countries of Europe
Pricing and Reimbursement in Brazil
Generics in Cardiovascular Diseases Market
Antibacterials Market
Arthritis Therapeutics Market
Patient Perspectives
Coal Mining Market
Iron Ore Mining Market in Europe
About Us
ResearchMoz is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across
industry verticals with our huge collection of market research reports. We
provide our services to all sizes of organizations and across all industry verticals
and markets. Our Research Coordinators have in-depth knowledge of reports
as well as publishers and will assist you in making an informed decision by
giving you unbiased and deep insights on which reports will satisfy your needs
at the best price.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY
12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-997-4948
Email
:
sales@researchmoz.com
http://www.researchmoz.com/
http://www.marketresearchreportsblog.com/
http://www.researchmoz.com/niche-market.html